Crawford Investment Counsel Inc. Has $16.39 Million Stock Holdings in Perrigo Company plc $PRGO

Crawford Investment Counsel Inc. cut its position in Perrigo Company plc (NYSE:PRGO) by 7.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,177,753 shares of the company’s stock after selling 96,714 shares during the period. Crawford Investment Counsel Inc.’s holdings in Perrigo were worth $16,394,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. Vanguard Group Inc. grew its stake in shares of Perrigo by 7.9% in the 4th quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock valued at $208,568,000 after buying an additional 1,101,154 shares during the period. Fuller & Thaler Asset Management Inc. grew its stake in shares of Perrigo by 291.9% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 7,824,759 shares of the company’s stock valued at $108,921,000 after buying an additional 5,828,076 shares during the period. Dimensional Fund Advisors LP boosted its stake in Perrigo by 2.4% during the 3rd quarter. Dimensional Fund Advisors LP now owns 7,695,238 shares of the company’s stock valued at $171,367,000 after purchasing an additional 181,828 shares during the last quarter. State Street Corp boosted its stake in Perrigo by 9.5% during the 2nd quarter. State Street Corp now owns 7,340,323 shares of the company’s stock valued at $196,134,000 after purchasing an additional 637,678 shares during the last quarter. Finally, Thompson Siegel & Walmsley LLC boosted its stake in Perrigo by 28.4% during the 4th quarter. Thompson Siegel & Walmsley LLC now owns 4,658,601 shares of the company’s stock valued at $64,848,000 after purchasing an additional 1,029,770 shares during the last quarter. 95.91% of the stock is currently owned by institutional investors and hedge funds.

Perrigo Price Performance

Perrigo stock opened at $10.66 on Wednesday. Perrigo Company plc has a 52 week low of $9.23 and a 52 week high of $28.43. The company’s 50 day moving average price is $11.18 and its two-hundred day moving average price is $12.41. The company has a quick ratio of 1.59, a current ratio of 2.72 and a debt-to-equity ratio of 1.45. The stock has a market cap of $1.47 billion, a P/E ratio of -0.81, a P/E/G ratio of 1.27 and a beta of 0.51.

Perrigo (NYSE:PRGO) last posted its earnings results on Wednesday, May 6th. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.39 by $0.04. Perrigo had a negative net margin of 43.50% and a positive return on equity of 9.96%. The firm had revenue of $841.80 million for the quarter, compared to analysts’ expectations of $1.04 billion. During the same quarter last year, the firm earned $0.60 EPS. The company’s quarterly revenue was down 7.2% compared to the same quarter last year. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. On average, equities analysts predict that Perrigo Company plc will post 2.11 earnings per share for the current year.

Perrigo Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Friday, May 29th were given a dividend of $0.29 per share. The ex-dividend date of this dividend was Friday, May 29th. This represents a $1.16 annualized dividend and a dividend yield of 10.9%. Perrigo’s dividend payout ratio (DPR) is currently -8.85%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on PRGO. Zacks Research upgraded Perrigo from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Weiss Ratings upgraded Perrigo from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday. Canaccord Genuity Group cut their price target on Perrigo from $20.00 to $17.00 and set a “buy” rating for the company in a research note on Friday, February 27th. Finally, Jefferies Financial Group reiterated a “hold” rating on shares of Perrigo in a research note on Thursday, February 26th. One research analyst has rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $19.33.

Perrigo Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.